Beranda › Penyakit Paru › Massachusetts
Uji klinis Penyakit Paru di Massachusetts
15 studi untuk Penyakit Paru mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Brigham and Women's Hospital, Boston
- Lucida Clinical Trials, New Bedford
- University of Massachusetts Chan Medical School, Worcester
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Brigham and Women's Hospital, Boston
- Clinical Trials Center, Boston
- Clinical Trials Hub, Boston
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Brigham and Women's Hospital, Boston
Menerima pesertaFase 2
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Dana Farber Cancer Institute, Boston
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Boston Medical Center, Boston
- Lahey Hospital & Medical Center, Burlington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Infinity Medical Research, North Dartmouth
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Boston
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- Beth Israel Deaconess Medical Center, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05967689A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Boston
Menerima pesertaFase 2
Usia 4 hingga 11 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07525375BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT05922761A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Massachusetts General Hospital,, Boston
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT02984761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Brigham and Women's Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT04555161Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.